![](https://img.medscapestatic.com/vim/live/professional_assets/medscape/images/thumbnail_library/gty_240705_hiv_drugs_injection_800x450.jpg)
No HIV Infections After Twice-a-Year PREP
Lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor, has shown 100% efficacy in preventing HIV in women at a high risk for infection, according to an interim analysis of the phase 3 PURPOSE 1 trial. The results were so promising that the …